Douching, talc use, and risk of ovarian cancer

NL Gonzalez, KM O'Brien, AA D'Aloisio… - …, 2016 - journals.lww.com
Background: Douching was recently reported to be associated with elevated levels of
urinary metabolites of endocrine disrupting phthalates, but there is no literature on douching …

Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation

AH Buchanan, CI Voils, JM Schildkraut, C Fine… - Journal of genetic …, 2017 - Springer
Identifying unaffected women with a BRCA mutation can have a significant individual and
population health impact on morbidity and mortality if these women adhere to guidelines for …

Hereditary breast and ovarian cancer syndrome: moving beyond BRCA1 and BRCA2

LN Hoang, BC Gilks - Advances in anatomic pathology, 2018 - journals.lww.com
The recent implementation of next generation sequencing and multigene platforms has
expanded the spectrum of hereditary breast and ovarian cancer syndrome, beyond the …

[HTML][HTML] Hereditary women's cancer: management and risk-reducing surgery

C Conte, S Pelligra, G Sarpietro, GD Montana… - Medicina, 2023 - mdpi.com
Hereditary women's syndromes due to inherited mutations result in an elevated risk of
developing gynecological cancers over the lifetime of affected carriers. The BRCA 1 and 2 …

Identification of high-risk germline variants for the development of pancreatic cancer: common characteristics and potential guidance to screening guidelines

C Bennett, M Suguitan, J Abad, A Chawla - Pancreatology, 2022 - Elsevier
Pancreatic cancer (PC) is a product of a variety of environmental and genetic factors. Recent
work has highlighted the influence of hereditary syndromes on pancreatic cancer incidence …

[HTML][HTML] Profile of pathogenic mutations and evaluation of germline genetic testing criteria in consecutive breast cancer patients treated at a North Indian tertiary care …

A Mittal, SVS Deo, A Gogia, A Batra, A Kumar… - Annals of Surgical …, 2021 - Springer
Background The burden of hereditary breast cancer in India is not well defined. Moreover,
genetic testing criteria (National Comprehensive Cancer Network [NCCN] and …

CDKN2A/p16 Genetic Test Reporting Improves Early Detection Intentions and Practices in High-Risk Melanoma Families

LG Aspinwall, SL Leaf, ER Dola, W Kohlmann… - … Biomarkers & Prevention, 2008 - AACR
Genetic testing for melanoma has yet to enter routine clinical use because of the scarcity of
available data on the effect of test reporting. A prospective study of 59 members of Utah …

High-intensity focused ultrasound in breast pathology: non-invasive treatment of benign and malignant lesions

B Cavallo Marincola, F Pediconi, M Anzidei… - Expert review of …, 2015 - Taylor & Francis
Breast neoplasms are one of the leading causes of morbidity and mortality in women. Even if
surgery is the treatment of choice, other forms of less invasive radical treatment are …

[HTML][HTML] Genomics applied to the treatment of breast cancer

D Hamdan, TT Nguyen, C Leboeuf, S Meles, A Janin… - Oncotarget, 2019 - ncbi.nlm.nih.gov
Breast cancer remains a major health issue in the world with 1.7 million new cases in 2012
worldwide. It is the second cause of death from cancer in western countries. Genomics have …

Enabling openness of valuable information resources: Curbing data subtractability and exclusion

P Vassilakopoulou, E Skorve… - Information Systems …, 2019 - Wiley Online Library
In this paper we investigate how data openness can be made possible in communal
settings. We adopt a utility perspective that foregrounds the use value of data …